Project: Human Cell Models for Retinal Therapeutic Discovery
| Acronym | RETINALYSIS (Reference Number: 113637) |
| Duration | 01/01/2020 - 01/07/2021 |
| Project Topic | The project will develop commercial cell-based products for use in preclinical drug discovery in the field of retinal degeneration, a main cause of blindness worldwide. The product shall combine the stem cell technology of Phenocell SAS (France) and the cryotechnology of AvantiCell Science Ltd (ACS; UK) to produce unique "plug and play" tools for drug screening and research. This model shall have the commercial advantages of first-to-market analytical performance and industry convenience. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 12 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | AvantiCell Science Ltd | Partner | United Kingdom |
| 2 | Phenocell SAS | Coordinator | France |